Zerodol PT Tablet is a combination analgesic formulation containing Aceclofenac 100 mg, Paracetamol 325 mg, and Tramadol 37.5 mg, designed for the effective management of moderate to severe pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis which leads to decreased inflammation and pain. Paracetamol acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. Tramadol, a centrally acting opioid analgesic, provides additional pain relief by binding to mu-opioid receptors and inhibiting the reuptake of norepinephrine and serotonin, enhancing descending inhibitory pain pathways. This combination is particularly beneficial in conditions such as osteoarthritis, rheumatoid arthritis, musculoskeletal disorders, postoperative pain, and other painful inflammatory conditions. Zerodol PT offers synergistic analgesic and anti-inflammatory effects while minimizing the dose-related adverse effects associated with individual components. It should be used under medical supervision, with caution in patients with hepatic, renal, or cardiovascular impairment, and avoided in individuals with hypersensitivity to any of its constituents. Common side effects may include gastrointestinal discomfort, dizziness, and nausea. Proper adherence to prescribed dosage is essential to maximize therapeutic benefits and minimize risks.